Background and aims 55 There is evidence that endocrine disrupting chemicals (EDCs) have developmental effects at 56 environmental concentrations. We investigated whether some EDCs are associated with the 57 adverse birth outcome Small for Gestational Age (SGA).
INTRODUCTION

92
A suboptimal intra-uterine environment can affect fetal growth and contribute to the risk of 93 developing adult diseases (Barker 1998) . The fetus depends on an accurate hormone balance 94 for its development (Diamanti-Kandarakis et al. 2009 ). Concern has risen since several . 205 An overview of the country-and sex-specific reference percentiles used for each cohort is 206 given in the Supplemental Material, Table S3 and Table S4 . Birth weight was extracted from 207 medical records collected in the birth cohorts and information on gestational age was 208 estimated from the questionnaires based on date of the last menstrual period and/or by 209 ultrasound. For HUMIS and some of the INMA cohorts, the data obtained from the last 210 menstrual period were replaced by ultrasound determination if the discrepancy between the 211 two methods exceeded 7-14 days (Table 1) . Table S6 ). There was no effect modification 
331
There was no effect modification indicated by child's sex for either PFOS or PFOA.
333
There was some evidence (p-interaction < 0.05), of effect modification by cohort, but the 334 direction of the estimates was not heterogeneous (data not shown). In general, additional 335 adjustment for GWG had no influence on the associations between EDCs and SGA, although 336 the estimates slightly reduced for PCB 153 (Supplemental Material, Table S9 ). The estimated odds ratios changed slightly, but the interpretation of the results remained when fitting the 338 final models again excluding the Roma participants (Supplemental Material, Table S10 ). In the current pooled analysis, significantly higher odds of SGA were observed with 386 increasing PCB 153 concentrations, and no significant associations were found for p,p'-DDE. 387 The positive association of PCBs with SGA was also observed by Lauritzen et al. and PCB 153 in girls whose mothers smoked during pregnancy. In our study a stronger 394 association was also seen in girls, but no effect modification by smoking was indicated. This . These studies were, however, too small to 398 explore effect modification by sex (n between 150-1057).
399
Our findings that HCB was significantly associated with increased odds of being SGA for 400 girls and decreased odds for boys are somewhat consistent with results found in a recent
401
Greek study (Vafeiadi et al. 2014) . In that study, HCB measured in maternal serum during was not affected, and both PCB 153 and HCB appeared to drive the association with SGA.
415
The association of HCB with SGA in girls was, however, less strong when mutually adjusting difficult to hypothesize the mechanism through which this effect modification is caused.
480
Since HCB is a known EDC it might also disrupt sex hormone pathways, and as such a 481 finding specific to girls or boys would not be unexpected. The biological mechanism 482 underlying the possible modifying effect of sex and smoking remains to be established. respectively an odds ratio of: 1.09 (girls) and 1.03 (boys) for PCB 153 (for an increase of 125 519 ng/L); 1.04 for HCB in girls (for an increase of 127 ng/L); 1.6 (smoking mothers during 520 pregnancy) for PFOS (for an increase of 1808 ng/L) and of 1.5 (non-smoking mothers during 521 pregnancy) and 2.2 (smoking mothers during pregnancy) for PFOA (for an increase of 901 522 ng/L). The results indicate that smoking, a well-known risk factor for SGA, is more strongly 523 associated with SGA, than the pollutants studied. On the other hand almost all babies had 524 measurable EDC concentrations and hence are exposed. In addition, for the perfluorinated 525 compounds the odds of SGA in those already exposed to maternal smoking were rather 526 substantial. The particular strength of this study was that by pooling the results, information was obtained 530 on the risks of being born small for gestational age. The pooled analysis included more than However, we also performed our analysis in a subset of the dataset with EDCs measured in 565 cord blood without applying any conversion factor as a sensitivity analysis and this did not 21.4 (16.5-37.6) Characteristics FLEHS I (Belgium, 2002 (Belgium, -2004 FLEHS II (Belgium, 2008 (Belgium, -2009 HUMIS (Norway, 2002 (Norway, -2006 INMA cord (Spain, 1997 (Spain, -2008 INMA mat (Spain, 2004 (Spain, -2008 LINC (The Netherlands, 2011 -2012 PCB cohort (Slovakia, 2002 (Slovakia, -2004 PELAGIE (France, 2002 (France, -2006 
